Jaisim Shah - Net Worth and Insider Trading

Jaisim Shah Net Worth

The estimated net worth of Jaisim Shah is at least $298,439 dollars as of 2024-10-30. Jaisim Shah is the See Remarks of Scilex Holding Co and owns about 265,215 shares of Scilex Holding Co (SCLX) stock worth over $263,703. Jaisim Shah is the SR VP, Mkt & Business Affairs of PDL BioPharma Inc and owns about 13,940 shares of PDL BioPharma Inc (PDLI) stock worth over $34,432. Jaisim Shah is also the Director of Sorrento Therapeutics Inc and owns about 112,633 shares of Sorrento Therapeutics Inc (SRNE) stock worth over $304. Details can be seen in Jaisim Shah's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jaisim Shah has not made any transactions after 2024-10-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Jaisim Shah

To

Jaisim Shah Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jaisim Shah owns 4 companies in total, including Sorrento Therapeutics Inc (SRNE) , LadRx Corp (LADX) , and PDL BioPharma Inc (PDLI) among others .

Click here to see the complete history of Jaisim Shah’s form 4 insider trades.

Insider Ownership Summary of Jaisim Shah

Ticker Comapny Transaction Date Type of Owner
SRNE Sorrento Therapeutics Inc 2018-11-26 director
LADX LadRx Corp 2009-05-04 Sr. VP - Business Development
PDLI PDL BioPharma Inc 2008-04-28 SVP & Mktg & Bus. Affairs
LIMIT LIMIT 2024-10-16 director & See Remarks

Jaisim Shah Latest Holdings Summary

Jaisim Shah currently owns a total of 3 stocks. Among these stocks, Jaisim Shah owns 265,215 shares of Scilex Holding Co (SCLX) as of October 29, 2024, with a value of $263,703 and a weighting of 88.36%. Jaisim Shah owns 13,940 shares of PDL BioPharma Inc (PDLI) as of April 30, 2007, with a value of $34,432 and a weighting of 11.54%. Jaisim Shah also owns 112,633 shares of Sorrento Therapeutics Inc (SRNE) as of June 15, 2017, with a value of $304 and a weighting of 0.1%.

Latest Holdings of Jaisim Shah

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SCLX Scilex Holding Co 2024-10-29 265,215 0.99 263,703
PDLI PDL BioPharma Inc 2007-04-30 13,940 2.47 34,432
SRNE Sorrento Therapeutics Inc 2017-06-15 112,633 0.00 304

Holding Weightings of Jaisim Shah


Jaisim Shah Form 4 Trading Tracker

According to the SEC Form 4 filings, Jaisim Shah has made a total of 3 transactions in Scilex Holding Co (SCLX) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Scilex Holding Co is the acquisition of 32,000 shares on October 29, 2024, which cost Jaisim Shah around $31,680.

According to the SEC Form 4 filings, Jaisim Shah has made a total of 0 transactions in PDL BioPharma Inc (PDLI) over the past 5 years. The most-recent trade in PDL BioPharma Inc is the sale of 16,440 shares on April 30, 2007, which brought Jaisim Shah around $427,440.

According to the SEC Form 4 filings, Jaisim Shah has made a total of 0 transactions in Sorrento Therapeutics Inc (SRNE) over the past 5 years. The most-recent trade in Sorrento Therapeutics Inc is the acquisition of 10,002 shares on June 15, 2017, which cost Jaisim Shah around $17,904.

Insider Trading History of Jaisim Shah

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jaisim Shah Trading Performance

GuruFocus tracks the stock performance after each of Jaisim Shah's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jaisim Shah is -8.2%. GuruFocus also compares Jaisim Shah's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jaisim Shah within 3 months outperforms 3 times out of 6 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Jaisim Shah's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Jaisim Shah

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
2 out of 5 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 15.46 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 14.8 LIMIT LIMIT LIMIT LIMIT LIMIT

Jaisim Shah Ownership Network

Ownership Network List of Jaisim Shah

No Data

Ownership Network Relation of Jaisim Shah

Insider Network Chart

Jaisim Shah Owned Company Details

What does Sorrento Therapeutics Inc do?

Who are the key executives at Sorrento Therapeutics Inc?

Jaisim Shah is the director of Sorrento Therapeutics Inc. Other key executives at Sorrento Therapeutics Inc include director & See Remarks Henry Ji , Chief Financial Officer Najjam Asghar , and See Remarks Jerome B Zeldis .

Sorrento Therapeutics Inc (SRNE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sorrento Therapeutics Inc (SRNE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sorrento Therapeutics Inc (SRNE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sorrento Therapeutics Inc (SRNE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Sorrento Therapeutics Inc Insider Transactions

No Available Data

Jaisim Shah Mailing Address

Above is the net worth, insider trading, and ownership report for Jaisim Shah. You might contact Jaisim Shah via mailing address: C/o Protine Design Lab, 37481 Marsten Dr, Newark Ca 94560.